Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Follow-Up of Patients With Complete Remission of Locally Advanced Basal Cell Carcinoma After Vismodegib Discontinuation: A Multicenter French Study of 116 Patients.
Herms F, Lambert J, Grob JJ, Haudebourg L, Bagot M, Dalac S, Dutriaux C, Guillot B, Jeudy G, Mateus C, Monestier S, Mortier L, Poulalhon N, Prey S, Robert C, Vabres P, Lebbe C, Meyer N, Basset-Seguin N. Herms F, et al. Among authors: mortier l. J Clin Oncol. 2019 Dec 1;37(34):3275-3282. doi: 10.1200/JCO.18.00794. Epub 2019 Oct 14. J Clin Oncol. 2019. PMID: 31609670
Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans.
Martin L, Piette F, Blanc P, Mortier L, Avril MF, Delaunay MM, Dréno B, Granel F, Mantoux F, Aubin F, Sassolas B, Adamski H, Dalac S, Pauwels C, Dompmartin A, Lok C, Estève E, Guillot B; French Group for Cutaneous Oncology. Martin L, et al. Among authors: mortier l. Br J Dermatol. 2005 Nov;153(5):932-6. doi: 10.1111/j.1365-2133.2005.06823.x. Br J Dermatol. 2005. PMID: 16225602
[Use of sorafenib in patients with hepatocellular or renal carcinoma].
Rosmorduc O, Chevreau C, Dielenseger P, Ederhy S, Goldwasser F, Grange JD, Mortier L, Neidhardt-Berard ME, Robert C, Scotté F, Seitz JF. Rosmorduc O, et al. Among authors: mortier l. Gastroenterol Clin Biol. 2010 Mar;34(3):161-7. doi: 10.1016/j.gcb.2009.12.004. Epub 2010 Feb 23. Gastroenterol Clin Biol. 2010. PMID: 20181452 Free article. Review. French.
[Expert consensus on the management of Merkel cell carcinoma].
Guillot B, Boccara O, Mortier L, Bens G, Girard C, Saiag P; le groupe d'experts. Guillot B, et al. Among authors: mortier l. Ann Dermatol Venereol. 2011 Jun-Jul;138(6-7):469-74. doi: 10.1016/j.annder.2011.02.028. Epub 2011 May 6. Ann Dermatol Venereol. 2011. PMID: 21700067 French.
[Guidelines for the diagnosis and treatment of Merkel cell carcinoma].
Boccara O, Girard C, Mortier L, Bens G, Saiag P, Guillot B; Groupe de cancérologie cutanée de la Société française de dermatologie. Boccara O, et al. Among authors: mortier l. Ann Dermatol Venereol. 2011 Jun-Jul;138(6-7):475-82. doi: 10.1016/j.annder.2011.01.029. Epub 2011 Mar 10. Ann Dermatol Venereol. 2011. PMID: 21700068 French.
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial.
Long GV, Trefzer U, Davies MA, Kefford RF, Ascierto PA, Chapman PB, Puzanov I, Hauschild A, Robert C, Algazi A, Mortier L, Tawbi H, Wilhelm T, Zimmer L, Switzky J, Swann S, Martin AM, Guckert M, Goodman V, Streit M, Kirkwood JM, Schadendorf D. Long GV, et al. Among authors: mortier l. Lancet Oncol. 2012 Nov;13(11):1087-95. doi: 10.1016/S1470-2045(12)70431-X. Epub 2012 Oct 8. Lancet Oncol. 2012. PMID: 23051966 Clinical Trial.
320 results